Goodrx Holdings, Inc. 8-K Filing

Ticker: GDRX · Form: 8-K · Filed: Nov 3, 2025 · CIK: 1809519

Goodrx Holdings, Inc. 8-K Filing Summary
FieldDetail
CompanyGoodrx Holdings, Inc. (GDRX)
Form Type8-K
Filed DateNov 3, 2025
Pages3
Reading Time4 min
Key Dollar Amounts$0.0001, $30,000, $10,000, $75,000, $230,000
Sentimentneutral

Sentiment: neutral

FAQ

What type of filing is this?

This is a 8-K filing submitted by Goodrx Holdings, Inc. (ticker: GDRX) to the SEC on Nov 3, 2025.

What are the key financial figures in this filing?

Key dollar amounts include: $0.0001 (hich registered Class A Common Stock, $0.0001 par value per share GDRX The Nasda); $30,000 (receive (i) an annual cash retainer of $30,000 for his service on the Board (pro-rate); $10,000 (an additional annual cash retainer of $10,000 for his service as the member of the No); $75,000 () an additional annual cash retainer of $75,000 for his service as Co- Chair of the Bo); $230,000 (ed stock units ("RSUs") with a value of $230,000 granted on such annual meeting date. A).

How long is this filing?

Goodrx Holdings, Inc.'s 8-K filing is 3 pages with approximately 890 words. Estimated reading time is 4 minutes.

Where can I view the full 8-K filing?

The complete filing is available on SEC EDGAR. You can also read the AI-decoded analysis with risk assessment and key highlights on ReadTheFiling.

Filing Stats: 890 words · 4 min read · ~3 pages · Grade level 14.3 · Accepted 2025-11-03 16:31:03

Key Financial Figures

  • $0.0001 — hich registered Class A Common Stock, $0.0001 par value per share GDRX The Nasda
  • $30,000 — receive (i) an annual cash retainer of $30,000 for his service on the Board (pro-rate
  • $10,000 — an additional annual cash retainer of $10,000 for his service as the member of the No
  • $75,000 — ) an additional annual cash retainer of $75,000 for his service as Co- Chair of the Bo
  • $230,000 — ed stock units ("RSUs") with a value of $230,000 granted on such annual meeting date. A
  • $420,000 — initial award of RSUs with a value of $420,000, which will vest as to one-third of the
  • $134,219 — d (b) an award of RSUs with a value of $134,219, which will vest in full on the earlier

Filing Documents

02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers;

Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. On October 31, 2025, GoodRx Holdings, Inc. (the "Company") and Trevor Bezdek, the Company's Co-Chairman of the Board of Directors (the "Board"), mutually agreed to end Mr. Bezdek's employment and executive officer service with the Company and its subsidiaries upon the expiration of his employment agreement on November 1, 2025. Mr. Bezdek will continue to serve as a Co-Chairman of the Board as a non-employee director. Compensation of Mr. Bezdek Following his termination of employment, as a non-employee director, Mr. Bezdek will be eligible to receive the standard compensation received by non-employee directors under the Company's second amended and restated Non- Employee Director Compensation Program (the "A&R Director Compensation Program") and will be permitted to participate in the Deferred Compensation Plan for Directors (the "Deferred Compensation Plan"). Under the A&R Director Compensation Program, Mr. Bezdek will be eligible to receive (i) an annual cash retainer of $30,000 for his service on the Board (pro-rated based on his service as a non-employee director during the 2025 fiscal year), (ii) an additional annual cash retainer of $10,000 for his service as the member of the Nominating and Corporate Governance Committee (pro-rated based on his service during the 2025 fiscal year) (iii) an additional annual cash retainer of $75,000 for his service as Co- Chair of the Board (pro-rated based on his service during the 2025 fiscal year and to which Scott Wagner will also be entitled) and (iv) if serving on the Board as of the date of the annual meeting of the Company's stockholders for a given calendar year, an annual award of restricted stock units ("RSUs") with a value of $230,000 granted on such annual meeting date. Additionally, in connection with Mr. Bezdek's transition to a non-employe

View Full Filing

View this 8-K filing on SEC EDGAR

View on ReadTheFiling | About | Contact | Privacy | Terms

Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.